Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

GHRP mimetics reported by Pfizer for treatment of osteoporosis

Jan. 29, 1997

Allelix develops antiinflammatory peptides

Jan. 29, 1997

HOP-1 claimed by Signal for treatment of CNS disorders

Jan. 29, 1997

Water-soluble camptothecin analogue reported by SKB

Jan. 29, 1997

Warner-Lambert develops antiretroviral agents

Jan. 29, 1997

RPR discloses novel polypeptides for cancer

Jan. 28, 1997

Thrombin inhibitors from BioChem Pharma

Jan. 28, 1997

Antibacterial and antineoplastic agents developed by Abbott

Jan. 28, 1997

Pharmacia & Upjohn claims camptothecin derivatives

Jan. 28, 1997

COX-2 inhibitors reported by Merck Frosst

Jan. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...